- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07273682
Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors
November 28, 2025 updated by: Dr Eva Ho, The Hong Kong Polytechnic University
A Nurse-facilitated Interdisciplinary Transitional Care Programme for Childhood Cancer Survivors and Their Parents to Improve Symptom Management: a Feasibility Randomised Waitlist-controlled Trial
This study aims to evaluate the feasibility and preliminary effectiveness of a nurse-facilitated interdisciplinary transitional care programme, based on the Omaha system, for Chinese childhood cancer survivors (CCSs) and their parents in Hong Kong.
Investigators will conduct a two-arm, randomized waitlist-controlled trial at the Hong Kong Children's Hospital, the only local center for CCS follow-up.
Sixty-eight dyads (CCS aged 13-18 and a parent) will be randomized to either the 12-week nurse-led intervention or usual care.
The intervention includes an initial face-to-face assessment and regular follow-ups via Zoom, focusing on symptom management, health education, and self-care empowerment, with referrals to other professionals as needed.
The control group receives standard discharge care and educational materials, and will be offered the intervention after data collection.
Outcomes will be assessed at baseline, and 3 and 6 months post-intervention, including symptom management, quality of life, caregiver burden, self-efficacy, and emergency department visits.
Feasibility will be evaluated by recruitment, retention, attendance, and data completeness rates.
If effective, this programme could improve transitional care and symptom management for CCSs and their families, and inform clinical practice and policy in Hong Kong and beyond.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ka Yan Ho
- Phone Number: +8527666417
- Email: kyeva.ho@polyu.edu.hk
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria for CCSs:
- aged between 13 and 18 years
- diagnosed with any cancer
- completion of active cancer treatment within a month
- communicate in Chinese
Inclusion Criteria for parents:
- mother or father who has a significant caregiving role in the child's life
- could participate in the intervention at the same time as their child
- communicate in Chinese
- have an electronic device to access zoom
Exclusion Criteria for CCSs:
- cognitive impairment
- social and/or behavioural problem
- have terminal cancer
- participate in any similar intervention
Exclusion Criteria for parents:
- severe emotional problems
- participate in any similar intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
|
Investigators developed the intervention based on the Omaha system and investigators' previous studies.
The intervention will last for 12 weeks.
During week 1, dyads (a pairing of a child with their parent) will have a 1-hour face-to-face consultation with a RN.
The RN will assess every dyad using the Omaha system to identify any problems.
The Omaha system covers 42 problems grouped into 4 categories, including environmental, physiological, psychosocial and health-related behaviours.
After identifying the problems, the RN will deliver corresponding interventions according to the intervention scheme in the Omaha system.
Subsequent follow-up will be provided by the RN via zoom during weeks 2, 3, 4, 6, 8, 10 and 12 to evaluate their progress in terms of knowledge, behaviour and status using the rating scale in the Omaha system.
The RN will assign further interventions, based on the Omaha system, to address their specific needs.
Each follow-up should last around 30 minutes.
|
|
Other: Wait-list control group
|
Investigators developed the intervention based on the Omaha system and investigators' previous studies.
The intervention will last for 12 weeks.
During week 1, dyads (a pairing of a child with their parent) will have a 1-hour face-to-face consultation with a RN.
The RN will assess every dyad using the Omaha system to identify any problems.
The Omaha system covers 42 problems grouped into 4 categories, including environmental, physiological, psychosocial and health-related behaviours.
After identifying the problems, the RN will deliver corresponding interventions according to the intervention scheme in the Omaha system.
Subsequent follow-up will be provided by the RN via zoom during weeks 2, 3, 4, 6, 8, 10 and 12 to evaluate their progress in terms of knowledge, behaviour and status using the rating scale in the Omaha system.
The RN will assign further interventions, based on the Omaha system, to address their specific needs.
Each follow-up should last around 30 minutes.
Dyads in this group will receive usual care, defined as the existing care practices provided by the hospital, which include a discharge checklist and educational materials regarding the care.
After the completion of data collection for all timepoints, they will be invited to join the counselling based on Omaha system intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Screening rate
Time Frame: Baseline
|
Number of dyads screened divided by number of dyads available for screening.
|
Baseline
|
|
Eligibility rate
Time Frame: Baseline
|
Number of dyads eligible divided by number of dyads screened.
|
Baseline
|
|
Recruitment rate
Time Frame: Baseline
|
Number of eligible dyads agree to join divided by number of eligible dyads.
|
Baseline
|
|
Randomization rate
Time Frame: Baseline
|
Number of dyads being randomized divided by number of participating dyads.
|
Baseline
|
|
Intervention attendance rate
Time Frame: Immediately after the intervention completion
|
Number of dyads who complete the intervention divided by number of dyads in the intervention group.
|
Immediately after the intervention completion
|
|
Retention rate
Time Frame: Baseline, immediately after the intervention completion, 3 months after intervention completion, 6 months after intervention completion
|
Number of dyads remaining in the study divided by number of dyads being randomized.
|
Baseline, immediately after the intervention completion, 3 months after intervention completion, 6 months after intervention completion
|
|
Completion rate
Time Frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
Number of dyads who complete the questionnaire divided by number of questionnaires distributed.
|
Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
|
Missing data
Time Frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
Percentage of missing data
|
Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
|
Adverse events
Time Frame: During the study period including 12-week intervention and 6 months follow-up
|
Number of unfavourable events and/or worsening reported.
|
During the study period including 12-week intervention and 6 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cancer-related symptoms in CCSs
Time Frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
It will be used to assess the cancer-related symptoms in CCSs.
It has 30 items in seven domains: nutrition-related, psychosocial/central nervous system, oropharyngeal, bone marrow toxicity/neuropathy, skin/other toxicities, neurotoxicity and respiratory/other.
Each item will be evaluated on a five-point scale, from 0 to 4. The psychometric properties have been well validated in CCSs.
|
Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
|
CCSs' quality of life (QoL)
Time Frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
Paediatric Quality of Life Questionnaire (PedsQoL) will be used to assess the CCSs' QoL.
It comprises 23 items.
CCSs will rate their experience during the preceding month on a five-point scale.
All items will be reverse-scored and linearly transformed onto a 0-100-point scale.
This scale has well-established psychometric properties in CCSs.
|
Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
|
Caregiver burden of parents
Time Frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
The caregiver burden in parents will be assessed using the Chinese version of the Caregiver burden inventory (CBI), which consists of 24 items in five dimensions: time-dependence, development, physical, social and emotional burdens.
Each item will be evaluated from 0 (not at all relevant) to 4 (very relevant), with the total score between 0 and 96.
The Chinese version is a valid and reliable instrument for use.
|
Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
|
Caregiving competence of parents
Time Frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
Caregiving competence scale (CCS) will be used to record the competence of parents regarding their caregiving.
This scale comprises four items, each of which is evaluated on a four-point rating scale, from 1 (not at all) to 4 (very much).
The psychometric properties of the Chinese version have been well established.
|
Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
|
Parental quality of life (QoL)
Time Frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
Parental QoL will be assessed using the Chinese version of the EQ-5D, with one question regarding each of five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
The values will be weighted to convert into a value from 1 (full health) to 0 (equivalent to being dead).
The psychometric properties of the EQ-5D have been well validated in the Chinese population.
|
Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion
|
|
Number of emergency department (ED) visits
Time Frame: During the study period including 12-week intervention and 6 months follow up
|
It will be assessed by number of walk-in visits to the emergency department.
These data will be collected in the central medical system with the assistance of PI in HKCH (Hong Kong Children's Hospital).
|
During the study period including 12-week intervention and 6 months follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
June 30, 2028
Study Registration Dates
First Submitted
November 19, 2025
First Submitted That Met QC Criteria
November 28, 2025
First Posted (Estimated)
December 9, 2025
Study Record Updates
Last Update Posted (Estimated)
December 9, 2025
Last Update Submitted That Met QC Criteria
November 28, 2025
Last Verified
October 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- nurse-facilitated care
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cancer
-
Rigshospitalet, DenmarkDanish Cancer Society; Danish Child Cancer FoundationNot yet recruitingPediatric Cancer | Pediatric Cancer PatientsDenmark
-
Associazione Italiana Ematologia Oncologia PediatricaRecruitingRehabilitation | Pediatric Cancer | Physical Therapy | Pediatric Oncology | Pediatric Cancer Patients | Motor OutcomesItaly
-
Ann & Robert H Lurie Children's Hospital of ChicagoSilicon Valley Community FoundationCompletedCancer | Pediatric CancerUnited States
-
University of BirminghamCompletedCancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AMLUnited Kingdom, Australia, Netherlands
-
Emory UniversityNational Cancer Institute (NCI)Completed
-
Eskisehir Osmangazi UniversityNot yet recruitingPediatric Cancer | Resilience, Psychological | Mobile Application | Coping | Adolescent Cancer | Pediatric NursingTurkey (Türkiye)
-
University of Witten/HerdeckeHeidehof Foundation Stuttgart; Community Hospital Herdecke; Nordoff/Robbins Music... and other collaboratorsRecruiting
-
Afyonkarahisar Health Sciences UniversityRecruiting
-
Children's Hospital Los AngelesRecruiting
-
University of California, San FranciscoWithdrawnPediatric CancerUnited States
Clinical Trials on Counseling based on Omaha system
-
Kutahya Health Sciences UniversityGazi UniversityCompletedHysterectomy | Sexual Function | Sexual Health | PLISSIT Model | Sexual Health Quality of LifeTurkey (Türkiye)
-
Istanbul Medeniyet UniversityIstanbul UniversityActive, not recruitingQuality of Life | Hip Arthropathy | Sexual Function DisturbancesTurkey
-
State University of New York at BuffaloCompletedOverweightUnited States
-
Università degli Studi del Piemonte Orientale "Amedeo...Lega Italiana per la Lotta contro i TumoriCompleted
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Catalan Institute of Health; University of BarcelonaCompletedSatisfaction | BirthSpain
-
Nazmiye GüneyEastern Mediterranean UniversityRecruiting
-
KTO Karatay UniversityKAMİLE ALTUNTUĞCompletedMaternal-Fetal Relations | Maternal BehaviorTurkey
-
Hasan Kalyoncu UniversityActive, not recruitingInflammatory Bowel Diseases | Crohn Disease | Colitis, UlcerativeTurkey
-
Oregon Health and Science UniversityCompletedObesity | Diabetes | Physical InactivityUnited States
-
Cyprus International UniversityCompletedQuality of Life | Osteoarthritis | Knee | Care Model | Nursing InterventionsTurkey